The AACC/Clinical Laboratory Expo is the leading event for clinical chemistry, clinical laboratory science and laboratory medicine products and services.
More than 20.000 participants are expected to attend the 2010 AACC/Clinical Lab Expo, making it a unique event for showcasing the company's forthcoming NGAL clinical chemistry test.
BioPorto Diagnostics will be at booth 6301 on all congress days. Members of the sales and marketing team and management will be available for discussions concerning licensing opportunities, partnering and distribution rights. Please refer to the contact details below to make an appointment.
BioPorto Diagnostics is presenting three scientific posters on NGAL at the meeting:
Poster No. A-18 -Evaluation of newly developed ELISAs for rat, mouse, dog and pig NGAL
Tuesday, July 27, 10:00 am - 12:30 pm / Animal Clinical Chemistry
Poster No. B-167 -Evaluation of a fully automated NGAL particle-enhanced turbidimetric test
Tuesday, July 27, 2:00 pm - 4:30 pm / Proteins/Enzymes
Poster No. C-33 - Urinary and plasma NGAL levels reflect the severity of acute kidney injury
Wednesday, July 28, 10:00 am - 12:30 pm / Clinical Studies/Outcomes
NGAL andThe NGAL Test
NGAL is a novel biomarker for diagnosing acute kidney injury (AKI). The key advantage of NGAL is that it responds earlier than other renal status markers and has a proportionate response to injury.
The NGAL Testwill be available for a wide range of clinical chemistry analyzers and will be launched in the beginning of 2011.The NGAL Testwill be able to determine NGAL levels in both urine and plasma within a standard routine timeframe.
For more information or to set up an appointment, please contact:
Klaus Boberg Pedersen, Human Diagnostics Product Manager, email@example.com
Trine Overgaard Østerbye, Sales and Marketing Manager, firstname.lastname@example.org
Ishan Gupta, Business Development Manager, Sales, email@example.com
For further information on the event: http://www.aacc.org/events/2010am/pages/default.aspx